Publication | Open Access

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial

Lymphoid NeoplasiaHigh-dose ClarithromycinMedicineImmunologyPathologyMucosa-associated Lymphoid TissueMetronomic ChemotherapyOncologyRadiation OncologyActive Monotherapy